RT Journal Article
SR Electronic
T1 Neuropsychological and social predictors of participation in a deep brain stimulation study of Parkinson’s disease and dystonia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.29.24308133
DO 10.1101/2024.05.29.24308133
A1 Hahn, Amelia
A1 Lazar, Ann A.
A1 Cernera, Stephanie
A1 Little, Simon
A1 Wang, Sarah S.
A1 Starr, Philip A.
A1 Racine, Caroline A.
YR 2024
UL http://medrxiv.org/content/early/2024/05/31/2024.05.29.24308133.abstract
AB Objectives Participation is essential to DBS research, yet circumstances that affect diverse participation remain unclear. Here we evaluate factors impacting participation in an adaptive DBS study of Parkinson’s disease (PD) and dystonia.Methods Twenty participants were implanted with a sensing-enabled DBS device (Medtronic Summit RC+S) that allows neural data streaming in naturalistic settings and encouraged to stream as much as possible for the first five months after surgery. Using standardized baseline data obtained through neuropsychological evaluation, we compared neuropsychological and social variables to streaming hours.Results Marital status and irritability significantly impacted streaming hours (estimate=136.7, bootstrapped (b) CIb=45.0 to 249.0, pb=0.016, and estimate=-95.1, CIb=-159.9 to -49.2, pb=0.027, respectively). These variables remained significant after multivariable analysis. Composite scores on verbal memory evaluations predicted the number of hours of data streamed (R2=0.284, estimate=67.7, CIb=20.1 to 119.9, pb=0.019).Discussion Verbal memory impairment, irritability, and lack of a caregiver may be associated with decreased participation. Further study of factors that impact research participation is critical to the sustained inclusion of diverse participants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was a sub-study of an adaptive deep brain stimulation study supported by National Institute of Health awards NINDS UH3NS100544, R01NS131405-01, and U24NS113667. This publication was also supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number CTSI UL1 TR001872. The sponsor was not involved in this study's design, the collection, analysis, or interpretation of data, nor in writing the report, nor the decision to submit the article to medRxiv.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was conducted as a sub-study of an adaptive DBS study which was approved by the institutional review board of University of California, San Francisco (IRB 18-24454).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors